IDEX Corporation

Greetings. Welcome to the IDEX Corporation first quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. The question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to your host, Jim Gianakouros. Thank you. You may begin.

Thank you. Good morning everyone and welcome to IDEX's first quarter 2025 earnings conference call. We released our first quarter financial results earlier this morning and you can find both our press release and earnings call slide presentation in the investor relations section of our website, idexcorp.com. On the call with me today are Eric Ashelman, President and Chief Executive Officer of IDEX and Abhi Kendallwal, our Senior Vice President and Chief Financial Officer. Today's call will begin with Eric providing highlights of our first quarter results and a discussion of our current business outlook and Abhi will discuss additional financial details and our updated outlook for 2025. Following our prepared remarks, we will open up the line for questions. But before we begin, please refer to slide two of our presentation where we note that comments today will include forward-looking statements based on current expectations. Actual results could differ materially from these statements due to a number of risks and uncertainties which are discussed in our press release and SEC filings. As IDEX provides non-GAAP financial information, we provided reconciliations between GAAP and non-GAAP measures in our press release and in the appendix of our presentation materials which are available on our website. With that, I will turn the call over to Eric.

Good morning everyone and thank you for joining us today. Before I dive in, I want to welcome Jim Gianakouros who joined us in March as our VP of investor relations. We're thrilled to have Jim in this role with the experience he brings. Welcome to the team, Jim. And now moving to slide three. Our IDEX teams delivered better than expected results in the first quarter of 2025 with revenue and profitability coming in slightly above plan in each of our business segments. I'd like to thank our IDEX teams across the globe for all their contributions, staying focused on serving our customers and executing through an environment of intensifying policy-driven uncertainty. I'm especially encouraged by our orders performance this quarter. Orders increased both sequentially and versus last year to record levels. Additionally, this represents our fourth consecutive quarter with positive -over-year organic growth in our order book. This combined with underlying stability in our day rate sets a firm foundation for growth near term. The trade and geopolitical situation continues to be fluid with the ultimate impact on global demand unknown. We are proactively managing what we can control and have been both quick and very thoughtful in actions designed to absorb the impact of tariffs introduced this year. Even though we have yet to see indications of a slowdown, we have proactively identified another $20 million in savings targets for this year. This amounts to a cumulative $80 million of support for 2025 when combined with the savings expected from our previously discussed platform optimization, organizational delayering, and baseline productivity initiatives. I'll be able to discuss this later in the call. Now I'd like to take you through our first quarter highlights. We're seeing momentum build in our businesses serving space, defense, energy transition, municipal water, and North American fire and safety. Our analytical instrumentation businesses within IDEX Health and Science continues to exhibit improving performance, trending towards low single-digit growth for the year, and our semiconductor MRO-facing businesses provide a slight tailwind. On the industrial side, our rapid turn businesses that often serve as leading indicators of economic change were steady in the first quarter, and that stability continued through the month of April. We recognize the potential for customer caution going forward, and we'll continue to actively monitor inbound order trends as our customers adapt to this fluid environment. We continue to see some setting headwinds in our businesses serving agriculture and automotive industries. Additionally, the inventory adjustment we are working through with a large semiconductor wafer fab customer continues to be a headwind. As you might expect, there is some hesitancy for customers to commit to larger projects, but it's at a level that matches both our recent experience exiting 2024 and supports assumptions within our 2025 annual guidance. We believe that the emerging order described here is a function of the active portfolio shape and driven over the last five years. We'll continue this work moving forward as we seek to grow through more increased exposure to advantage markets. To achieve the next level of growth performance, we continue to drive our own luck by tuning our technologies towards high-velocity applications. We support these efforts with focused cross-business collaboration wherever possible as customers push us to innovate faster. We lean on our intuitive understanding of 80-20 to pull organizations together in pursuit of clear objectives and outcomes. Here are some examples. Our Richter business, facing headwinds in its core European chemicals markets, has adapted its severe duty valves for fast-growing pharmaceutical applications where they've won in a big way. Our Abell pump business is winning an extremely difficult environment supporting mining of strategic minerals. They have another segment the business focused on marine defense applications. Both of these 80s verticals are extremely advantaged at the moment. A number of our optics businesses are working together to help solve the most challenging problems for the emerging space sector from low-orbit satellite communication support to critical components within hypersonic systems. Our air tech business within performance pneumatics is helping their customers solve power requirements for the rapidly growing data center market in a way that best supports sustainable solutions. They have recently brought some of Mott's technologies into discussions on next generation solutions to help solve critical problems with scalability. Speaking of Mott, our latest acquisition and our largest to date, I'm pleased to report that the teams there continue to deliver against our expectations. Mott recently entered into a $40 million multi-year agreement to deploy a custom wastewater filtration solution for a large U.S. dairy farm operation that'll treat over 2 million gallons of wastewater a day. To give you a sense of timing, roughly 25% of this order has been booked in Q1 and it's expected to be delivered as sales in the second half of the year. At IDEX, our teams are laser focused on speed and increased agility to meet the evolving needs of our customers. Our teams are fully committed to not only execute on our collective near-term commitments but drive sustainable value creation for all stakeholders in the long run. With that, I'll now hand it over to Eric to give us his thoughts on our 2025 outlook.

Thanks, Eric, and good morning, everyone. Let's go to slide four. As Eric mentioned, we outperformed our guidance for the first quarter across revenue, margin, and adjusted earnings per share. Now, all comparisons I will discuss will be against the prior year period, understated otherwise. In the first quarter, organic sales declined 1% as we faced difficult comps in our semiconductor, agriculture, chemical, and energy businesses, which more than offset positive results in space, defense, and municipal water-facing businesses. We continued to see resilient demand all in for IDEX with organic orders up 1% and backlog building by about 60 million. Adjusted EBITDA margin declined 50 basis points to 25.5%, given -over-year volume D leverage and near-term margin dilution from our acquisition of Mock. And these were partially offset by positive price cost and productivity, including our announced platform optimization efforts. First quarter, 2025 adjusted EPS of $1.75 came in 10 cents better than the high end of our guided range, given better than expected sales and margins across segments, and timing of corporate costs, most notably share-based compensation. We generated $91 million of free cash flow in the quarter, which included short-term investments in working capital to support higher sales in the second quarter, as well as some modest purchasing ahead of inventory intended to slow tariff impact. Additionally, we deployed $50 million to repurchase IDEX shares in the first quarter, and we have $490 million left with our current authorization. On slide five, turning to the drivers of our adjusted EBITDA, a decline in volume resulted in an $8 million reduction flowing through at a prior year adjusted gross margin rate. We additionally experienced unfavorable overhead leverage, which was more than offset by platform optimization savings and favorable price cost, which was accrued to margins. Acquisitions, investitures, and effects benefited adjusted EBITDA by $3 million. Now quickly, some color on our sales by segment. I'm on slide six. In HST, organic sales in the first quarter declined 1%, while our organic orders actually increased 3%. We are seeing solid activity in a performance pneumatics group driven by growth in data center power solutions and in space and defense with a number of our optics businesses. We see steady trends in life sciences with an analytical instrumentation more than offsetting lower DNA sequencing orders. Our semiconductor business, specifically where we provide solutions that support wafer fabrication, faces headwinds. Adjusted EBITDA margins of .6% was slightly better than we anticipated, primarily due to benefits from higher than expected volumes in the first quarter. Turning to slide seven. In FMT, organic sales declined 4% and organic orders declined 3%. While we continue to see relative strength in municipal water and downstream energy markets and relative stability in our core industrial markets, we are also experiencing near-term pressures in our chemicals and ag businesses. Finally, our business supporting pure water applications within semiconductor fabs has slowed. Adjusted EBITDA margin of .8% declined 80 basis points as volume D leverage was only partially offset by price, cost, and productivity improvements, including platform optimization savings. I'm on slide eight. FSD turned another solid quarter with organic sales increasing 5% and organic orders up 2%. Our fire and safety business continues to benefit from both strong OEM demand and adoption of integrated solutions. Bandit experience growth in energy with aerospace remaining stable. We continue to build upon our leadership position in dispensing their overall global trends are stable and auto remains special. Adjusted EBITDA margin of .4% increased 50 basis points due to favorable volume leverage, price, cost, and productivity. Now, please turn to slide nine for updated full year and second quarter guidance. We are maintaining our full year organic growth guidance range of 1 to 3% and adjusted EPS of $8.10 to $8.45. Although the situation is still evolving, we believe we can fully absorb the tariffs introduced this year based on our current assumptions. I will provide our detailed tariff assumptions on the next slide. We expect to fully mitigate tariff pressure largely through incremental pricing actions. We're navigating a fluid and uncertain environment and the impact of this on underlying demand is challenging to predict, particularly in the short time or rapid replenishment areas of our business. While we have not observed any immediate signs of demand softening through April, we acknowledge that it could manifest as the year plays out given policy driven uncertainty. We have proactively identified an additional $20 million of savings that we are deploying against scenarios of up to 3 to 4% back half volume pressure. For the second quarter, we anticipate organic revenue growth of flat to 2%. We expect second quarter adjusted EBITDA margin to be between .5% to 27%. Up 100 basis points or more sequentially on higher volumes, positive price, and greater traction on our platform optimization and delayering savings. This generates expected second quarter adjusted EPS of $1.95 to $2.05. Please turn to slide 10, which outlines our tariff exposure as it stands today. We expect tariffs to drive $100 million of annualized impact based on 2025 volumes with two thirds of that amount to be recognized in 2025. On an annualized basis, we expect that tariffs will add 5% to 6% to our cost of goods sold, which can be offset by price increases of 3 to 4%. I want to take a moment to emphasize how IDEX thrives during times of disruption. In particular, IDEX benefits from its local for local manufacturing footprint, the flexibility provided by its 80-20 principles, and the strength of its long-standing customer partnerships. Additionally, as Eric previously mentioned, we have the ability to adapt our technology to new applications, which further positions us for success. Now, I'd like to pass it back to Eric.

Thanks, Ubhi. Please turn to slide 11. I'm excited about the IDEX we're building. Today, over half of IDEX is on ways to collaborate, sell, and leverage scale within thematic growth platforms. This is an important strategic shift we've made to elevate our long-term performance in advantage spaces with combined total addressable markets of just over $20 billion. We've identified a series of specific integrative threads that we believe support higher growth and expanded margins as we come together within these groups in a unique IDEX way. We deploy flat organizational structures with autonomous decision rights, sharp 80-20 segmentation, while solving the most critical customer solutions with quick iterative bursts of innovation. I'm on slide 12. We have a strong balance sheet supported by superior cash flow generation to explore multiple avenues of capital deployment. Our corporate development team, alongside our business leaders, continues to work an active M&A pipeline. We'll continue to deploy capital to expand and deepen our capabilities within our growth platforms, and we remain committed to turning capital to shareholders. Finally, turn to slide 13. We believe IDEX is advantaged and therefore prepared to navigate an increasingly uncertain trade and geopolitical environment. We generally ideate, engineer, source, produce, and sell our products locally. Our businesses are well positioned within attractive markets, and we enjoy long and productive relationships with outstanding customers. As the world becomes more regionalized, we can adapt with customers and transition local for local support across the globe with speed. 80-20 is deeply embedded in our diverse set of businesses. We are constantly looking to tune our solutions to apply them in new applications and markets, and we can shift resources quickly from areas with developing slack capacity to structurally advantaged markets. Putting it all together, we are improving and leveraging each of our key value drivers, organic growth, inorganic growth, and margin expansion. We collectively believe that change and uncertainty, no matter how unsettling they can be in the near term, ultimately present opportunities for our trusted solutions as we help our customers win. With that, I'll turn it over to the operator for your questions.

Thank you. We will now be conducting a question and answer session. If you would like to ask a question, please press star 1 on your telephone keypad. The confirmation tone will indicate your line as in the question queue. You may press star 2 if you would like to remove your question from the queue. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys. One moment please while we poll for your questions. Our first questions come from the line of Mike Halloran with Baird. Please proceed with your questions.

Thank you. Morning, everyone. Hey, Mike. Just want to make sure I understand the puts and takes and the guidance here and what's embedded. I mean, I think the punch line is I think you feel comfortable with the guide and the ability to have some flexibility to manage some of the inputs depending on what materializes. One, is that right? And then two, could you just go through those puts and takes? It seems like FX is more of a tailwind, put the incremental 20 million cost savings, a little lower volume, a little higher price. I mean, maybe just kind of walk through those two different assumptions I talked to there.

Yeah, Mike, I can do that. I'll break it up for you and kind of follow the sequential pattern here. So just starting with Q1, again, recalibrating everybody on the call here. As I think about our performance for Q1, our organic came in better than what we had, you know, what we provided, which was down three to four. We came in down about a point. Good start to the year in terms of EPS. So as I kind of look forward and think about the cadence of 2Q and then the rest of the year, and I'll touch on tariff in a second, coming into any given quarter, we're about 50% bucked. So as I look at our outlook for Q2 coming into this quarter, and Eric alluded to it in his remarks, we haven't seen our order pattern shift in April. So as of last night, our orders continue to remain in line with expectations. So as I think about Q2 and the current outlook of 0 to 2%, our backlog supports it, which then translates into $1.95 to $2.05. As I then fast forward into Q3 and Q4 and think about the back half of the year, what this outlook incorporates is a Q3 HST ramp from 2 to 3 of 10 million, 10 million from 3 to 4. FMP's staying at the same levels and FSDP's staying at the same levels, which then gets you to the 1 to 3% for the year. From a tariff standpoint, what we have assumed in the guide is the two-third impact of $100 million. So call it 60 to 65 million impact in this outlook, and we're going to offset that -for-one with price. The incremental $20 million of cost out is a proactive measure, even though we haven't seen our volumes move. We have proactively deployed those in the likely event that we see our quick lead times, rapid replenishment cycle businesses slow.

Perfect. That's super helpful here. Then maybe just talk about, look, we're in a little different scenario relative to normal. If we get some pressure points from a macro perspective in your businesses, normally that happens after a period of expansive growth, not as much frequency happening against the periods of headwinds you've seen over the last years. Maybe talk about how you see the portfolio shaping up if we do get some pullback, what that resilience looks like, how you frame it. I know you have a lot of those offsets as you have from a growth initiative perspective, and how does that balance things out?

Obviously, unprecedented times in a number of respects, as you said. As I said on the slide that highlighted how we've set ourselves up with five very, very strong growth platforms. We've got them lined up. We're talking with customers and innovating in areas that in many ways I think are in markets that are rapidly developing, kind of irrespective of some of these forces. We've got a lot of resources and weight tilted towards delivering on those solutions. All of IDEX right now has been leaned out and optimized through multiple rounds of productivity. Just to recap that, we came into the year, we always have baseline productivity lined up that starts on January 1st. We added that de-layering and platform optimization work, a lot of it in these areas of growth platforms, a lot of it in HST, so we had that ready to go early on. Then candidly, we just thought, hey, this is an environment that says we can do more with less, we know how to do that here, and we laid that in for mitigation and protection in the back half of the year. When you look at it, you've got a bunch of franchises that are well positioned. We deliver critical, incredibly valuable solutions at frankly low price points. We protected ourselves from the impact of terrorists, at least the ones that have been announced here today, and we're engaging in a way that we always do via 80-20, super sharp places and areas that are advantaged and probably hold up better to any of the shocks that are running around at the time, just because of the nature of the solutions that we're after. I think this is where 80-20, our credibility and reputation as operators, the two things come together and putting about as much resilience as we can imagine at a time with no doubt a lot of uncertainty.

Thank you.

Thank you. Our next questions come from the line of Nathan Jones with Stiefel. Please proceed with your questions. Good morning, everyone.

Good morning, Nathan. I guess I'll start with a question about tariffs and pricing. Talking about two-thirds of the tariffs falling within the year and pricing falling within the year implies that the market has not seen tariff impacts or pricing impacts yet. Is that fair? Are those coming down the probably in May or June, potentially the catalysts? It sounds like you are anticipating some of the short cycle business demand drops off. Is that when you expect to start seeing that impact of customers actually seeing the dollars on their invoices?

Yeah, Nathan, this is a bit, let me take a stab at it. If you think about the 100 million, that's of course an annualized figure and we provided the details in terms of what it is by that set as I take a step back and think about where we are. We are sitting here in April and the April 1st day of May. What we have seen so far is, and we do hold some inventory, so what we have seen so far is a small impact in Q2 with majority of this impact we are going to see in Q3 and Q4. If you think about the cadence of the 60-65 million, I would say 10-12 million is what we are expecting in Q2 and the balance 25-25 in Q3 and Q4. That's how we are thinking about it but keep in mind it is also about what you are buying, when you are buying it and how much do you hold in inventory.

I think I get the spirit of parts of your question here. Through much of April, I think a lot of this is kind of off the radar. It is something that everybody knows is coming. It has been announced by us and others. You will see the IDEX side of it take hold probably faster just because of the nature of we don't have as much inventory and we turn things with quicker lead times and we were pretty urgent and aggressive on price capture that we thought we had to have. But I think you will see this start to cascade and build as we go through May and probably especially into June, just giving inventory positions and announcements and things and then really kind of full steam on the back half and that's where I think we and others will be looking for, okay, what is the collective impact of that and frankly are there other modifications? Remember, that is sort of two parallel tracks that are working together.

Okay, thanks for that. I am going to ask one that is not related to tariffs. I wanted to have you guys talk a little bit more about the combining of some of these businesses into these strategic growth platforms. I think probably I certainly didn't understand until I was out with you guys on the road in the first quarter and talked more about it. I think it is probably a little bit misunderstood by investors as well about what the potential benefits, what the potential growth outcomes are longer term from combining these businesses, delayering these businesses. So I am hoping you could go into a little more detail and explain the rationale behind it and what you think benefits are going to be.

Sure, sure. Again, we are always careful with this at IDEX. This absolutely still leaves decision rights locally with these businesses and these platforms and we are super careful about the integrative threads that we weave between them in terms of what dimension and where that adds value. What this isn't is a massive bureaucracy with multiple organizational layers. In fact, it is actually the opposite. In my prepared remarks, there were actually two examples of this starting to come together. On the growth side, I will highlight those and give you a bit more insight. I talked about our performance pneumatics business and our recent acquisition AirTech and the work that they are doing around power solutions, frankly, sustainable power solutions for the data center market. That business singularly has done great work over the years and continuing to evolve it and it was a decent part of the story in Q1. They are actually able to now bring in Mott and some of the technology that they have there for a different and related specific application that actually helps scalability to the next level in a way that, frankly, the AirTech business never could by themselves. And no other company really could because those two technologies typically don't exist in a way that they do at IDEX. Now, it is still early days. We will see that whole frontier and move it forward. I would say that aspect right at the tip of the spear of technology is probably front and center, what we are really after more than any other thing. I talked about it in optics as we talked about low orbit space communication and hypersonic travel.

We have got

great optics franchises that we have assembled over time, Iridium being the last. They have multiple points where they are playing in that space. Picture this as engineers working together in complementary ways where one business' 20 years of legacy is now teamed up with another business' 20 years to develop something that, again, is pretty novel. It doesn't really exist and it doesn't really have a competitive offering or offset just simply because of the advantage scale that we have put together there. Again, it is relative to kind of our world and our size, but it is important in these markets. And then as we talked about the multiple tranches of productivity that we have laid out and we talked about this last quarter, just this organizational ability to span things and span functions a little differently gives us a kick in productivity that helps fuel the innovation on the other side. So if we are selling, let's say, to a single customer here and doing it across multiple businesses, kind of the old IDEX that would have been supported with stand-alone commercial organizations and then the cartoon version of this would have had multiple people in the same lobby calling on the customer, we don't have to do that anymore. That is actually advantaged and preferred by the customer and it is a lot cheaper to run on our side. We can take those resources and funnel it right back into technology. So it is those little extensions and those connection points between businesses, think of them as sparks and lightning bolts. That is what we are celebrating, but doing it in a very, very IDEX way, flat organizational structure, local decision rights, everything we kind of know and expect with IDEX, but we have been able to amplify it in this way.

Yeah, Nathan, just to build on what Eric said, so you touched on the delayering work that we did as part of year-end, but there are more chapters to it. So as you think about the five scalable platforms that Eric is talking about, there is a second chapter around footprint consolidation, around looking at that landscape and really starting to consolidate some footprint, which would be the second layer of this cost allocation towards growth and then third layer of the cost allocation. So we are going to have to build more pieces around with this level of scale. We get an opportunity to go after sourcing savings and drive more productivity. So that is chapter two and three. More will come on that as we move forward, but this is the advantage of having this level of scale and being able to drive the level of integration that Eric is talking about.

Very helpful. Thanks very much for taking my questions.

Thanks, Nathan.

Thank you. Our next questions come from the line of Vlad Bysterky with City Group. Please proceed with your questions.

Good morning, guys. Thanks for taking my question here.

Maybe just start off for me. I think the Mott project win that you highlighted was actually quite interesting. Can you just talk about whether that is something that is fairly unique or whether you see that opportunity as something that could be repeatable and meaningful for other customers? Do you see other opportunities, similar opportunities out there for Mott?

Yes. So this is actually a small technology acquisition that Mott made before our acquisition. And so the thesis very much was in line with what this project represents. So it is really, advanced filtration that is being deployed in this particular case at pretty massive scale, livestock application. But essentially, we are processing the waste stream of dairy cows and things like that. And you kind of get two products at the end of it. You have pure fertilizer on the one side and very, very clean water on the other side. And you essentially are delivering environmental friendliness with kind of resultant products that have their own potential for productivity. So that kind of is the core thesis of what this business and business model represents. I must admit, this is probably at the right edge and the higher edge of the scale, just simply because of where this is being applied in this particular case. It is an outstanding reference case. It is going to take us a while to engineer it, put it out there. But get it in place. That is why we talked about the specific timing of the bookings and the way it is going to run out in the back half of the year. It does support partially that HST ramp that Abid talked about later. But it is going to be an outstanding reference case for a business that is just kind of starting to launch within Mott. But this is like right down the fairway of kind of the core argument, the core fundamental argument of what we are trying to achieve.

No, it definitely sounds interesting. I appreciate that, Eric. And then maybe just a quick follow-up from me. I think you mentioned that you did take in a little extra inventory here in one queue just ahead of tariffs. I guess the follow-up question to that, have you seen any evidence from your customers of them pulling forward any order activity, if you will?

Yep. So look, that is always a tricky one for us across all businesses with a pretty customized product. So it has never been the best inventory to stack on shelves anyway. But we absolutely went looking for it just because you can imagine the same dimension that we responded to. I mean, for us it was a pretty modest amount for much of the same reasons. We found a couple of pockets of it. I think, you know, we went and talked to people, talked to distributors and others. I think in the end of the day, what did we say? We said six

to eight million dollars.

I think, you know, we went to places, looked for box levels where we go. We hang out a lot and just didn't see a ton of it, but we allow that there is probably that level. And it is, honestly, it is pretty equivalent to the little bit that we did.

Yep. Great. That is helpful. I will get back into you.

Thank you. Our next questions come from the line of Joe Giordano with Cowan. Please proceed with your questions.

Good morning, guys. Good morning, Joe. So I wanted to talk on the, and apologies if you mentioned this in the very beginning of your prepared remarks, but

the

confidence now in the semiconductor recovery, or at least the resumption of those orders in the second half that we talked about last quarter, I mean, I feel like the updates that we have been getting on semi is generally negative so far this learning season, so I am just curious if there is any update on that.

Yeah. So there are kind of two things going on. I think we would agree with the overall sentiment, the industry. There has been more headlines about restrictions and things like that. And so, you know, if you think of our business, it is split. We do a fair amount of it, and the majority of it is kind of right in the heart of, you know, essentially the machine tool in the wafer fab, and then a companion piece on the metrology and inspection side. I did mention in the prepared remarks, though, that we saw some pretty good performance. We had some growth tailwinds on the MRO-facing side of the business. Now, that had historically for us been in the ceiling areas, so these are consumable items. They wear out over time, and they are reflective of just using the system. It is a little better now because as Mott has come into the picture, Mott's exposure in the space has a, it is essentially a gas filter, so it is a consumable element as well. And so they both win new platforms and then have this recurring revenue stream. So it tilts us a little bit more in that direction, and that was favorable for us. So I alluded to that, but I did say on the back side, same thing that you are seeing here. We probably see a push out, an extension of ultimate recovery here on high-cost, cutting-edge machine tools, and I think we are seeing the same thing as we talk to our customers. So they don't necessarily balance themselves out, so we have a little bit of net pressure in the back half of the year from that space, but are certainly happy to have this higher level of MRO exposure.

Hey, Joe, just to kind of bring it all together in terms of outlook, because I think your question towards that will eventually turn into outlook. So again, let me just recalibrate. If I take a step back, again, think about Q1, as I mentioned earlier, we came in better than expected. Our EPS performance was better than expected. Coming into second quarter, as I look at our outlook, look at the forward, looking where we are headed from Q2 and beyond, our backlog position in Q2 supports the 0 to 2 percent organic. And then as I look forward and kind of think about the outlook, we are at a 3Q, 4Q, HST is a $10 million ramp from 2 to 3, 3 to 4, and really that's driven by the backlog that we built for MOT that's going to ship in the back half of the year, the strength that we are seeing in pharma, space, and defense. And then FMT is pretty much going to be at the same levels, and FSDP at the same levels of 2Q revenue to be able to get to our outlook of 1 to 3 percent. So that's on the top line. On the bottom line, though, if you think about it, a third of our bottom line outlook is driven by the volume pieces I just articulated for you, but the two-thirds is tied to things that are in flight, in motion, i.e., cost optimization, delaring, stepping up in the back half. The cost piece that we laid out for $20 million as part of this conversation, that's back half. And then the timing of share base comes from first half to second half, which is pretty significant, which is almost 12 cents. So again, a third of this first half, second half earnings ramp is tied to the revenue pieces I just laid out. Two-thirds is tied to in-flight controllable actions that are part of this outlook.

Before I get to my follow-up, just maybe if I can clarify what you just said there, are you saying that some of that semi-ramp with maybe like Muon and the large customers is like effectively been replaced with MOT and the 1Q beats and things like that? We arrive at the same place, but maybe it's not as dependent on those large orders?

That is correct.

Okay. And then just question on the strategic growth platforms. I mean, that's somewhat new. Is there any sense of rebranding companies as a -to-market as one entity or as one overarching team? I know that's not how this is typically done in the past, but it sounds a little bit more like that just in the commentary. So just curious how you think about individual brands versus like an IDEX franchise that goes to customers.

It's a good point. And in actual fact, this part has been evolving alongside for a while now. I mean, to be honest, a lot of the thinking here is actually built on kind of what happened in IDEX Health and Sciences over the last 10 years. And we do and have for a while now branded that as IDEX Health and Science. At the same time, we still celebrate the individual brands and the brand equity that we have there. So it's a bit of a hybrid. As we move through this and evolve, you see that today in IDEX Fire and Safety. I mean, we very much present ourselves that way out in the market, but at the same time, then celebrate Hearst, Jaws of Life, Hale, those individual sub brands. We're doing the same thing probably in an emerging perspective with an intelligent water. Two, three years ago, you would go to a West Tech or one of the trade shows and see five different booths. We actually have brought those together over the last couple of years, but never lose sight of the individual accumulated brand equity. It's a much lighter touch in severe duty flow control. That's where frankly, those individual equity stories are the highest and all we're really integrating there. It's kind of front end customer acquisition through digitization at this point. So that's light to none. And then over on the material sciences solution side, that's just purchased, just accumulated. There's no point in branding that at this level. So I think that matters, but for us, it's indicative of when you reach a state of evolution where, you know, frankly, the customers are starting to say, this is what we want. We actually want the capitalization that IDEX provides. We recognize now that these solutions could only happen because IDEX exists and has brought them together. And then even when we, you know, introduce and put IDEX on the side of the box, we never subordinate completely those individual brands.

Great

color.

Thank

you.

Thank you. Our next questions come from the line of Brian Blair with Oppenheimer. Please proceed with your questions.

Thank you. Come on, yes. Hi, Tim.

You've referenced steady day rates a few times. So I imagine directionally, and I know what the response will be, but I was curious if you could offer some detail on order trends at Warren Ruck Gas and Bandit over March and April. Just curious what the real time reads have been from those primary type businesses pre- versus post-territory?

Yeah, I mean, look, as I think Eric mentioned it, I alluded to it. As I think about the businesses you're talking about, Eric and I track them on a weekly basis, daily basis. We look at the order trends, compare them to last week, last quarter. And what we've seen in Q1, and frankly to 5 p.m. of last night, is order trends that have been steady and are in line with our expectation. We have seen no movement, if you will, on those order trends.

There's really nothing identifiable based on news of the day externally where the next day it pivots or changes. I mean, they always ebb and flow a bit day to day, but we look at the kind of moving average and we look at how it tracks across them. That actually tells you more when they line up and move the same way, given the breadth and the difference in businesses. That's where we get the most intel. And then, you know, this time of year as well is also good for us. We have a fair amount of distributor conferences where we bring everybody together into different businesses and we get the opportunity to then have three-dimensional conversations around those day-rate data. And we just had one of those, the biggest one last week. Same story. Kind of consistently people saying, hey, things are holding up. My customers are doing well. They're still acquiring things. The systems are working. There is hesitancy on bigger projects. I talked about that, but honestly that's been pretty consistent for a while now. And then lots of captive energy about, I wonder what comes next. That's absolutely there too.

Of course. That's helpful, Coler. Thank you. And I understand at any point in time there's only so much that your team can discuss on this front, but maybe offer just a high-level update on the VM&A environment and how, if at all, the uncertainty of this backdrop has affected your team and your M&A strategy.

Yeah. Well, I think there's no question that in terms of people looking to transact quickly and legitimize where their business is going to go and all the things you would need to do to make a transaction move fast in the near term. I think you see that pretty slow for not just us, but for everybody. We always kind of divide this activity into buckets. So I would say the lion's share of the work that people are doing is really at that conversational diligence level of getting to know people. Remember about 80% of the deals we've done in the last few years have been proprietary. That's the way we prefer it. We like taking our time getting to know a business like Mott. And so that was a multi-year conversation. We have other conversations like that going on and they don't change or ebb and flow. In fact, in some ways they get more intensive around changes like this and how that shapes how a team thinks about its business. So big category of work that doesn't get affected. That work around near term transactions, I think you can imagine that's slower now. I mean, the number of people offering us things from out of the blue is certainly slower for all the reasons you'd expect, but that really isn't a feeder stock for us anyways. So I think that this is a speed bump in many ways, but it doesn't interrupt the overall quality of the work or the work that we're doing and frankly, our future vision for what we can deploy.

That makes sense and encouraging. Thanks again.

Thank you. Our next questions come from the line of Dean Dre with RBC Capital Markets. Please proceed with your questions.

Thank you. Good morning, everyone. Hey, Dean. Hey, maybe you can expand on your earlier comment on the strength in municipal water. I mean, the idea here is that's probably the most defensive of defensive verticals just because so much of it is OPEC and non-discretionary and projects are locked in and so forth. But just any color there in terms of the outlook. Thanks.

Yeah. Yeah. No, I think you're right. It's very, very defensible business. And then again, the work that we do is very localized around the wastewater side of things and critical analytics as we examine that infrastructure and help our customers dig into how it's working. So that kind of protect there's some natural resiliency there on two fronts. One, you know, the things that thunderstorms and things that could be affected by climate. I mean, they're not affected by trade policy. And so, you know, the need for people to understand that, mitigate it. I think last night I saw there were floods again in Oklahoma. You know, that's the work we do. A lot of our businesses are helping with flow monitoring and understand where the system broke down and how it should be remediated. And so, you know, that's really unaffected. There's some natural resiliency from frankly some probably unfortunate variable inputs. On the other side, remember to the extent there's funding support for this, it's broad and it extends over multiple years. Our end customer for a lot of these businesses is actually the specification engineers which are putting together the capital projects that goes and grabs some of that funding. So, you know, if we're in a multi-year wave of stronger strength within municipal water, our positioning at the front end of it is it's got some natural resiliency as well just because we're helping people figure out how that they're going to appropriate those funds, ask for them, request them and put them to work. So I think some of it is just sector driven, as you said, Dean. I think a lot of it is just the nature of what we do, what we've localized around and the natural resiliency of that kind of work.

Yeah, it's what's from what we can see, the stormwater management is one of the fastest growing water sector verticals, both because of the funding but also the fines that the EPA is pursuing against cities if they're not addressing it. Are you seeing both of these driving the stormwater management?

Yeah, the sort of regulatory side of this has always been a driver for this business.

Yep. Good. And then just separately, you know, anytime there's heightened uncertainty, it has a fallout on M&A in terms of, you know, if there's a fall off in multiples, the sellers have a way of being pretty sticky and remembering what their business was worth, you know, just a few months ago. So and they'll even pull some transactions until things settle out. You know, just what's been your perspective here, real time on the kind of funnel and multiples?

Yeah, well, I think you're right that quality business is tended to be very sticky around those valuation expectations. If anything, uncertainty then tends to draw things out to wait for good times to return so that everything can be back to normal again. So the timing probably more than very, you know, valuations, I would say being impacted by something like this, this round of uncertainty. You know, for us, I mean, we're just at a period with, I mean, we're really doing two things in this area. We're spending a lot of time kind of optimizing, building and integrating on, you know, frankly, the higher activity that we've brought into the company through M&A. So we're doing a lot of work there. And then around these growth platforms, I mean, as I talked about in the comments, there's a lot of room to run. And so we're doing a lot of exploratory work, initial conversations. So that whole chapter, as I said before, doesn't really go down at this point. In fact, in some ways, people are more available for it now. And then on the other side, you know, we're looking at some interesting bolt-ons. We've got a framework here with over half of the company with natural attachment points. And so I think around, you know, some nice bolt-on work that could happen here over the next couple

of quarters

would be very good.

Terrific. And I was remiss at not welcoming Jim to the team and best of luck. Thanks, Dean.

Thank you. As a reminder, if you would like to ask a question, please press star one on your telephone keypad. Our next questions come from the line of Brett Lindsay with Mizzouho. Please proceed with your questions.

Hey, good morning, all. I wanted to come back to the organic sales outlook, the one to three unchanged from the previous outlook. Sounds like the composition has maybe changed a little bit. I was hoping maybe you could just mention that. So, you know, you're getting the three to four points of incremental tariff-induced pricing. I imagine you had some price embedded in the original assumption. Is it fair to say prices up and you're taking a little bit more hedge on the volume side? Any thoughts there?

Absolutely. I can walk you through it. So the original outlook that we had laid out of one to three implied a price of point and a half. So as you kind of think about the full year outlook, the way we see it today, that hasn't changed. What that does incorporate is an additional point and a half of price on a full year basis. So if you think about the current outlook, it is assuming three points of price for the full year and the volume being down 2% at the low end and being flat at the high end. Okay. As I alluded, as I mentioned, we've not seen our April order rates move, but proactively we have gone out and identified an incremental $20 million of cost that we're taking out, which then gives us protection from 3% to 4% volume decline in the back half of the year.

All right. Got it. I appreciate that. And then just a follow-up on some of the government spending or the austerity measures under DOJ and the new administration, are you seeing any spending reductions or impact on grants driving customer spending decisions at this point? And then maybe update on the core life science customer base and what you're seeing there from an order perspective.

Yeah. So on your first question, I mean, not a lot directly. I don't... The kind of work we do is more iterative and not massively project dependent. So to the extent there's some impact there, it's harder to read and it hasn't really presented itself and we've talked about that in our daily rates. Life science is an area where it does come up because there's obviously been some work towards NIH funding, but that's a pretty low percentage ultimately for our customers and the read through for us is kind of low percentage as well. And frankly, in our life science markets, the strength in pharma sort of offsets it. And so that's one area where the headline, you can hear about it, hear about a little closer to home, but it's at a low impact level and we offset it. I would say generally in places that it might be presenting itself elsewhere in the business, again, I think it's probably being offset by some of the strength we've seen in defense applications, space. So it's netting out at present if it's there. And again, because of the nature of sort of project work that we do or the lack of it, you just... It doesn't present itself as a big impediment at present. It's sort of one of those things that I think people are speculating about direction and ultimate impact, but really hasn't landed anywhere near us yet.

All right, got it. Pursuit the detail, best of luck. Thank you.

Thank you. Our next questions come from the line of Matt Somerville with the DA Davidson. Please proceed with your questions.

Thanks. Just maybe first, just to follow up, I want to make sure I understand this. You're basically saying that through this incremental proactive cost out, you can absorb a 3% to 4% organic sales decline in the second half of the year, but that is not how you've guided the top line. Do I have that correct?

So when you said 2% to 4% year over year, what I'm saying is if you think about the $20 million of cost out and think about a prior outlook to a current outlook, it will absorb 3% to 4% top line decline with that $20 million. So it's outlook to outlook shift.

It would absorb the volume component. We would get some of the price capture would stand in.

Okay. And then as you look at kind of the... Maybe you can comment too, as the year has unfolded through the first four months, realizing that inbound orders have been healthy, have you seen any discernible trend in sequential cadence in orders? And are you getting any sort of sense that you have customers, especially in kind of your more distribution facing businesses, are buying ahead? And if so, can you maybe try to quantify that? Thank you.

I'd say the cadence has been pretty uniform through each of the four months. In the majority of our business, maybe elevating and growing a little bit with more strength than HST, but largely that's because of the winds. We saw places like Mott in defense and space. So, they're attributable to things you'd want to see in a business. Everything else pretty stable. We talked a little earlier about the buy ahead. I mean, we looked and looked and looked and think it's

at relatively

low levels. I think we talked... What did we say just a second ago? It would be? Something like that. It kind of matches the same percentage that we did. It's unusual for us to do it. Kind of unusual for a customer base, but we found evidence that we're sort of in line on that. So, we don't think it's a big number, but wouldn't say it's

zero. Got it. I missed that six to eight. Thanks for clarifying that.

Thank you. We have reached the end of our question and answer session. I would now like to turn the floor back over to Eric Ashland for closing comments.

Thank you very much, Shade, and thanks for everybody for joining the call today. Obviously, as we discussed this morning, it's a dynamic and fluid situation as global trade relationships are reset and redefined. But I just ask that we remember that some things don't change at IDEX. Our businesses are really strong. I mean, they're just outstanding. We deliver a ton of critical value at price points that are low relative to the total cost of the customer solution. We enjoy really long and productive relationships with world-class customers. I think our number one job now is to support those same customers as they navigate the same uncertain waters that we're looking at with innovation, agility, and global breadth. And as we do that, we'll keep our fingers on the pulse of prevailing economic trends and control what we can control, adjust where we need to, and clearly communicate our latest thinking as we move through the next phase of change. Thanks again for your interest and support at IDEX, and have a great day.

Thank you. This does now conclude today's teleconference. We appreciate your participation. You may disconnect your lines at this time. Enjoy the rest of your day.